Statistiche di base
| LEI | 3538001UOKRWIODYM055 |
| CIK | 1593129 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to M3, Inc. - Depositary Receipt (Common Stock)
SEC Filings (Chronological Order)
Questa pagina fornisce un elenco completo e cronologico dei depositi SEC, esclusi i documenti di proprietà che forniamo altrove.
| February 4, 2014 |
EXHIBIT 1 Notice regarding determination of stock exchange ratio for the short-form stock exchange between M3, Inc. |
|
| February 4, 2014 |
CB/A 1 j131140cba2.htm AMENDMENT NO. 2 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form CB TENDER OFFER/RIGHTS OFFERING NOTIFICATION FORM (AMENDMENT NO. 2) Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to file this Form: Securities Act Rule 801 (Rights Offering) o Securities Act Rule 802 (Exchange Offer) x Exchange Act Rule |
|
| January 9, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form CB TENDER OFFER/RIGHTS OFFERING NOTIFICATION FORM (AMENDMENT NO. 1) Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to file this Form: Securities Act Rule 801 (Rights Offering) o Securities Act Rule 802 (Exchange Offer) x Exchange Act Rule 13e-4(h)(8) (Issuer Tender Offer) o Exc |
|
| January 9, 2014 |
Notice of Extraordinary Meeting of Shareholders [Attached hereto] EX-1 2 ex1.htm EXHIBIT 1 Exhibit 1 EXHIBIT 1 Notice of Extraordinary Meeting of Shareholders [Attached hereto] (Company code: 2182) January 8, 2014 To Our Shareholders: 1-1-7 Higashi-nihonbashi, Chuo-ku, Tokyo Mediscience Planning Inc. Akinori Urae, Chairman and Chief Executive Officer Notice of Extraordinary Meeting of Shareholders The Company hereby invites shareholders to attend an Extraordinar |
|
| December 3, 2013 |
EXHIBIT 1 Notice regarding the execution of a stock exchange agreement related to M3 Inc. |
|
| December 3, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form CB TENDER OFFER/RIGHTS OFFERING NOTIFICATION FORM (AMENDMENT NO. ) Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to file this Form: Securities Act Rule 801 (Rights Offering) o Securities Act Rule 802 (Exchange Offer) x Exchange Act Rule 13e-4(h)(8) (Issuer Tender Offer) o Exch |
|
| December 3, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-X APPOINTMENT OF AGENT FOR SERVICE OF PROCESS AND UNDERTAKING A. Name of issuer or person filing (“Filer”): M3, Inc. B. (1) This is [check one] x an original filing for the Filer o an amended filing for the Filer (2) Check the following box if you are filing the Form F-X in paper in accordance with Regulation S-T Rule 1 |
